Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties; ACS Molecular Pharmaceutics; Vol. 16, No. 3
| Parent link: | ACS Molecular Pharmaceutics Vol. 16, No. 3.— 2019.— [P. 995–1008] |
|---|---|
| Awdur Corfforaethol: | Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория № 31 ядерного реактора |
| Awduron Eraill: | Deev S. M. Sergey Mikhaylovich, Vorobjeva (Vorobyeva) A. G. Anzhelika Grigorjevna, Shulga (Schulga) A. A. Aleksey Anatolievich, Proshkina G. M. Galina Mikhaylovna, Guler R. Rezan, Lofblom J. John, Mitran B. Bogdan, Garousi J. Javad, Altai M. Mohamed, Buijs J. Jos, Chernov V. I. Vladimir Ivanovich, Orlova A. M. Anna Markovna, Tolmachev V. M. Vladimir Maksimilianovich |
| Crynodeb: | Title screen Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins that can be selected for binding to desirable molecular targets. High affinity and small size of DARPins render them promising probes for radionuclide molecular imaging. However, detailed knowledge on many factors influencing their imaging properties is still lacking. We have evaluated two human epidermal growth factor 2 (HER2)-specific DARPins with different size and binding properties. DARPins 9_29-H6 and G3-H6 were radiolabeled with iodine-125 and tricarbonyl technetium-99m and evaluated in vitro. A side-by-side comparison of biodistribution and tumor targeting was performed. HER2-specific tumor accumulation of G3-H6 was demonstrated. A combination of smaller size and higher affinity resulted in a higher tumor uptake of G3-H6 in comparison to 9_29-H6. Technetium-99m labeled G3-H6 demonstrated a better biodistribution profile than 9_29-H6, with several-fold lower uptake in liver. Radioiodinated G3-H6 showed the best tumor-to-organ ratios. The combined effect of affinity, molecular weight, scaffold composition, and nonresidualizing properties of iodine label provided radioiodinated G3-H6 with high clinical potential for imaging of HER2. Режим доступа: по договору с организацией-держателем ресурса |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1021/acs.molpharmaceut.8b00922 |
| Fformat: | Electronig Pennod Llyfr |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664012 |
Eitemau Tebyg
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4
Cyhoeddwyd: (2024)
Cyhoeddwyd: (2024)
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors; International Journal of Molecular Sciences; Vol. 26, iss. 21
Cyhoeddwyd: (2025)
Cyhoeddwyd: (2025)
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer; Cancers; Vol. 15 - iss. 12
Cyhoeddwyd: (2023)
Cyhoeddwyd: (2023)
Validation of an Analytical HPLC Method for a New Diagnostic Octreotide Derivative for Neuroendocrine Tumors; Pharmaceutical Chemistry Journal; Vol. 53, iss. 9
Cyhoeddwyd: (2019)
Cyhoeddwyd: (2019)
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake; International Journal of Molecular Sciences; Vol. 22, iss. 5
Cyhoeddwyd: (2021)
Cyhoeddwyd: (2021)
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors; Cancers; Vol. 15 - iss. 6
Cyhoeddwyd: (2023)
Cyhoeddwyd: (2023)
Cyclotron Production of 99Mo Radionuclide by Bombarding Zirconium Targets with Alpha Particle Beams; Russian Physics Journal; Vol. 62, iss. 4
Cyhoeddwyd: (2019)
Cyhoeddwyd: (2019)
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, iss. 10
Cyhoeddwyd: (2025)
Cyhoeddwyd: (2025)
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer; Pharmaceutics; Vol. 13, iss. 2
Cyhoeddwyd: (2021)
Cyhoeddwyd: (2021)
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3; Nuclear Medicine and Biology; Vol. 124-125
Cyhoeddwyd: (2023)
Cyhoeddwyd: (2023)
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer; Theranostics; Vol. 13, iss. 14
Cyhoeddwyd: (2023)
Cyhoeddwyd: (2023)
Phase I Clinical Trial Using [99mTc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients; Pharmaceutics; Vol. 14, iss. 6
Cyhoeddwyd: (2022)
Cyhoeddwyd: (2022)
Cross section of the 96Zr(α,n)99Mo reaction induced by α-particles beams on natZr targets; Applied Radiation and Isotopes; Vol. 166
Cyhoeddwyd: (2020)
Cyhoeddwyd: (2020)
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer; Cancers; Vol. 16, iss. 16
Cyhoeddwyd: (2024)
Cyhoeddwyd: (2024)
Разработка модели малогабаритного экстрактора с саморегулируемым уровнем границы раздела фаз для разделения пары 99Мо/99MТс; Известия Томского политехнического университета [Известия ТПУ]; Т. 323, № 3 : Химия
Cyhoeddwyd: (2013)
Cyhoeddwyd: (2013)
Cardioprotective Properties of Opioid Receptor Agonists in Rats WithStress-Induced Cardiac Injury; Physiological Research; Vol. 68, iss. 3
Cyhoeddwyd: (2019)
Cyhoeddwyd: (2019)
Получение нового наноколлоидного радиофармпрепарата на основе оксида алюминия; Известия Томского политехнического университета [Известия ТПУ]; Т. 323, № 3 : Химия
Cyhoeddwyd: (2013)
Cyhoeddwyd: (2013)
Радиохимический комплекс на основе меченных 99mТс антимикробных пептидов UBI29-41 и UBI18-35 для дифференциальной диагностики септического воспаления костей конечностей; Бюллетень экспериментальной биологии и медицины; Т. 170, № 10
Cyhoeddwyd: (2020)
Cyhoeddwyd: (2020)
Assessment of radiological techniques application possibility for non-invasive diagnostics of latent inflammatory processes in myocardium in patients with atrial fibrillation; Annals of Nuclear Medicine; Vol. 30, iss. 10
Cyhoeddwyd: (2016)
Cyhoeddwyd: (2016)
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin; Pharmaceutics; Vol. 11, iss. 5
Cyhoeddwyd: (2019)
Cyhoeddwyd: (2019)
Однофотонная эмиссионная компьютерная томография с 99mTC-1-ТИО-d-глюкозой в диагностике и стадировании злокачественных лимфом: первый опыт использования; Сибирский онкологический журнал; Т. 17, № 4
Cyhoeddwyd: (2018)
Cyhoeddwyd: (2018)
Receiving of nanosized colloids based on modificated dtpa molecule labeled with technetium-99m; 7th International Symposium on Technetium and Rhenium - Science and Utilization
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Synthesis and experimental study of norfloxacin labeled with technetium-99m as a potential agent for infection imaging; Iranian Journal of Nuclear Medicine; Vol. 23, Iss. 2
Cyhoeddwyd: (2015)
Cyhoeddwyd: (2015)
Obtaining technetium-99m labeled nanocolloids based on aluminum oxide for medical diagnostics; 7th International Symposium on Technetium and Rhenium - Science and Utilization
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Получение на циклотроне радионуклида 99Mо путем облучения пучком a-частиц мишени из циркония; Известия вузов. Физика; Т. 62, № 4 (736)
Cyhoeddwyd: (2019)
Cyhoeddwyd: (2019)
Application of NANOcolloid Materials Labeled by Radionuclides in Medicine; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)
Cyhoeddwyd: (2015)
Cyhoeddwyd: (2015)
Preparation Technique of Technetium-99m-Labeled Nanoparticles of Fe@C with Modified Surface; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)
Cyhoeddwyd: (2015)
Cyhoeddwyd: (2015)
Experimental study of radiopharmaceuticals based on technetium-99m labeled derivative of glucose for tumor diagnosis; IOP Conference Series: Materials Science and Engineering; Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine
Cyhoeddwyd: (2016)
Cyhoeddwyd: (2016)
Synthesis and Study of Norfloxacin Labeled with Technecium-99m as a Potential Imaging Agent of Bacterial Inflammations; Key Engineering Materials; Vol. 685 : High Technology: Research and Applications 2015 (HTRA 2015)
Cyhoeddwyd: (2016)
Cyhoeddwyd: (2016)
Изучение процесса взаимодействия технеция-99м с нанодисперсными производными комплексонов ДТПА; Известия вузов. Физика; Т. 56, № 11-3
Cyhoeddwyd: (2010)
Cyhoeddwyd: (2010)
Obtaining Technetium-99m-Labeled Glucose Derivatives; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)
Cyhoeddwyd: (2015)
Cyhoeddwyd: (2015)
Radiolabeled Complex of Antimicrobial Peptides UBI29-41 and UBI18-35 Labeled with 99mTc for Differential Diagnosis of Bone Infection of the Limbs; Bulletin of Experimental Biology and Medicine; Vol. 170, iss. 4
Cyhoeddwyd: (2021)
Cyhoeddwyd: (2021)
Development new radiopharmaceutical based on 5-thio-d- glucose labeled technetium-99m; IOP Conference Series: Materials Science and Engineering; Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine
Cyhoeddwyd: (2016)
Cyhoeddwyd: (2016)
A procedure for sorbent pretreatment for the production of high-activity99Mo/99mtc generators based on enriched98Mo; Radiochemistry; Vol.54, iss. 4
Cyhoeddwyd: (2012)
Cyhoeddwyd: (2012)
Получение меченных технецием-99м нанодисперсных производных комплексонов ДТПА; Фундаментальные исследования; № 10-7
Cyhoeddwyd: (2013)
Cyhoeddwyd: (2013)
Экспериментальные испытания меченных технецием-99м коллоидных препаратов; Естественные и технические науки; № 5 (95)
Cyhoeddwyd: (2016)
Cyhoeddwyd: (2016)
Исследование процесса адсорбции технеция-99м на оксидах алюминия; Физико-технические проблемы атомной энергетики и промышленности
Cyhoeddwyd: (2010)
Cyhoeddwyd: (2010)
Создание автоматизированного модуля для экстракционно-хроматографического разделения генераторной пары 99Мо/ 99mTC; Радиохимия; Т.56, №2
Cyhoeddwyd: (2014)
Cyhoeddwyd: (2014)
Сравнение влияния стратегий мечения технецием-99м адресных молекул DARPin G3 на биораспределение и визуализацию экспрессии HER2; Физико-технические проблемы в науке, промышленности и медицине
Cyhoeddwyd: (2022)
Cyhoeddwyd: (2022)
Adsorption of 99mTc on aluminum oxide; Radiochemistry; Vol. 53, iss. 5
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Eitemau Tebyg
-
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4
Cyhoeddwyd: (2024) -
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors; International Journal of Molecular Sciences; Vol. 26, iss. 21
Cyhoeddwyd: (2025) -
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer; Cancers; Vol. 15 - iss. 12
Cyhoeddwyd: (2023) -
Validation of an Analytical HPLC Method for a New Diagnostic Octreotide Derivative for Neuroendocrine Tumors; Pharmaceutical Chemistry Journal; Vol. 53, iss. 9
Cyhoeddwyd: (2019) -
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake; International Journal of Molecular Sciences; Vol. 22, iss. 5
Cyhoeddwyd: (2021)